Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Papp

Showing results (121-130 of 460) with videos related to

Pageof 46
Sort By:
American Journal of Clinical Dermatology|November 9, 2015
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical TrialsKim A Papp, April W Armstrong, Kristian Reich, et al.
Journal of Chromatography|November 30, 1990
Quantitation of didanosine in human plasma and urine by high-performance liquid chromatographyC A Knupp, F A Stancato, E A Papp, et al.
Burns : Journal of the International Society for Burn Injuries|November 10, 2005
Red blood cell and tissue water content in experimental thermal injuryA Papp, E Romppanen, T Lahtinen, et al.
Burns : Journal of the International Society for Burn Injuries|October 12, 2004
The progression of burn depth in experimental burns: a histological and methodological studyA Papp, K Kiraly, M Härmä, et al.
Applied Optics|March 18, 2010
Magnetooptical current transformer. 2: ComponentsH Aulich, W Beck, N Douklias, et al.
Lancet (London, England)|February 5, 2016
Ixekizumab for psoriasis--Authors' replyChristopher E M Griffiths, Kim A Papp, Susan G Ball, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2018
Response to 'Psoriasis patients' preference for an aerosol foam topical formulation' by Vender R et alC-H Hong, K A Papp, K W Lophaven, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Long-term management of plaque psoriasis with continuous efalizumab therapyAlan Menter, Craig L Leonardi, Wolfram Sterry, et al.
Journal of Cutaneous Medicine and Surgery|October 24, 2017
Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community PracticesLuvneet Verma, Julia N Mayba, Melinda J Gooderham, et al.
Journal of Drugs in Dermatology : JDD|March 6, 2014
Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regionsAlan Menter, Kim A Papp, Huaming Tan, et al.
Pageof 46

Showing results (121-130 of 460) with videos related to

Sort By:
Pageof 46
American Journal of Clinical Dermatology|November 9, 2015
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical TrialsKim A Papp, April W Armstrong, Kristian Reich, et al.
Journal of Chromatography|November 30, 1990
Quantitation of didanosine in human plasma and urine by high-performance liquid chromatographyC A Knupp, F A Stancato, E A Papp, et al.
Burns : Journal of the International Society for Burn Injuries|November 10, 2005
Red blood cell and tissue water content in experimental thermal injuryA Papp, E Romppanen, T Lahtinen, et al.
Burns : Journal of the International Society for Burn Injuries|October 12, 2004
The progression of burn depth in experimental burns: a histological and methodological studyA Papp, K Kiraly, M Härmä, et al.
Applied Optics|March 18, 2010
Magnetooptical current transformer. 2: ComponentsH Aulich, W Beck, N Douklias, et al.
Lancet (London, England)|February 5, 2016
Ixekizumab for psoriasis--Authors' replyChristopher E M Griffiths, Kim A Papp, Susan G Ball, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 11, 2018
Response to 'Psoriasis patients' preference for an aerosol foam topical formulation' by Vender R et alC-H Hong, K A Papp, K W Lophaven, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Long-term management of plaque psoriasis with continuous efalizumab therapyAlan Menter, Craig L Leonardi, Wolfram Sterry, et al.
Journal of Cutaneous Medicine and Surgery|October 24, 2017
Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community PracticesLuvneet Verma, Julia N Mayba, Melinda J Gooderham, et al.
Journal of Drugs in Dermatology : JDD|March 6, 2014
Efficacy of tofacitinib, an oral janus kinase inhibitor, on clinical signs of moderate-to-severe plaque psoriasis in different body regionsAlan Menter, Kim A Papp, Huaming Tan, et al.
Pageof 46